The Risks of Medical Innovation (eBook, ePUB)
Risk Perception and Assessment in Historical Context
Redaktion: Schlich, Thomas; Tröhler, Ulrich
46,95 €
46,95 €
inkl. MwSt.
Sofort per Download lieferbar
23 °P sammeln
46,95 €
Als Download kaufen
46,95 €
inkl. MwSt.
Sofort per Download lieferbar
23 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
46,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
23 °P sammeln
The Risks of Medical Innovation (eBook, ePUB)
Risk Perception and Assessment in Historical Context
Redaktion: Schlich, Thomas; Tröhler, Ulrich
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Presenting a new way of thinking about the risks of medical innovation, this volume considers the issues from a social historical perspective, and studies specific cases in their respective contexts.
- Geräte: eReader
- mit Kopierschutz
- eBook Hilfe
- Größe: 13.67MB
Andere Kunden interessierten sich auch für
- Richard SzostakTechnological Innovation And The Great Depression (eBook, ePUB)42,95 €
- Trine Stauning WillertInnovation in the Orthodox Christian Tradition? (eBook, ePUB)46,95 €
- Barbara Bridgman PerkinsCancer, Radiation Therapy, and the Market (eBook, ePUB)56,95 €
- M. Basheer AhmedThe Rise and Fall of Muslim Civilization (eBook, ePUB)8,95 €
- Mark KurlanskyThe Basque History of the World (eBook, ePUB)4,99 €
- Josep L BaronaThe Rockefeller Foundation, Public Health and International Diplomacy, 1920-1945 (eBook, ePUB)42,95 €
- Bernd GausemeierHuman Heredity in the Twentieth Century (eBook, ePUB)56,95 €
-
-
-
Presenting a new way of thinking about the risks of medical innovation, this volume considers the issues from a social historical perspective, and studies specific cases in their respective contexts.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 320
- Erscheinungstermin: 2. August 2004
- Englisch
- ISBN-13: 9781134312375
- Artikelnr.: 38261198
- Verlag: Taylor & Francis
- Seitenzahl: 320
- Erscheinungstermin: 2. August 2004
- Englisch
- ISBN-13: 9781134312375
- Artikelnr.: 38261198
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Thomas Schlich is Canada Research Chair in the History of Medicine at the Department of Social Studies of Medicine at McGill University, Canada. Ulrich Tröhler heads the Institute for the History of Medicine of the University of Freiburg, Germany.
Preface. Risk and Medical Innovation: A Historical Perspective. To Assess
and to Improve: Practitioners? Approaches to Doubts Linked with Medical
Innovations 1720-1920. Anaesthesia and the Evaluation of Surgical Risk in
Mid-Nineteenth Century Britain. Redemption, Danger, and Risk: The History
of Anti-Bacterial Chemotherapy and the Transformation of Tuberculin. As
Safe as Milk or Sugar Water?: Perceptions of Risks and Benefits of the BCG
Vaccine in the 1920s and 1930s in France and Germany. From Danger to Risk:
The Perception and Regulation of X-Rays in Switzerland 1896-1970. The
Population as Patient: Alice Stewart and the Controversy over Low-Level
Radiation in the 1950s. To Treat or Not to Treat: Drug Research and the
Changing Nature of Essential Hypertension. Hormones at Risk: Cancer and the
Medical Uses of Industrially-Produced. Sex Steroids in Germany, 1930-1960.
Assessment and Medical Authority in Operative Fracture Care in the 1960 and
1970s. Assessing the Risk and Safety of the Pill: Maternal Mortality and
the Pill. Addressing Uncertainties: The Conceptualisation of Brain Death in
Switzerland 1960-2000. Risk on Trial. The Interaction of Innovation and
Risk in Cancer Clinical Trials. BioRisk: Interleukin-2 from Laboratory to
Market in the United States and Germany. The Redemption of Thalidomide:
Standardizing the Risk of Birth Defects
and to Improve: Practitioners? Approaches to Doubts Linked with Medical
Innovations 1720-1920. Anaesthesia and the Evaluation of Surgical Risk in
Mid-Nineteenth Century Britain. Redemption, Danger, and Risk: The History
of Anti-Bacterial Chemotherapy and the Transformation of Tuberculin. As
Safe as Milk or Sugar Water?: Perceptions of Risks and Benefits of the BCG
Vaccine in the 1920s and 1930s in France and Germany. From Danger to Risk:
The Perception and Regulation of X-Rays in Switzerland 1896-1970. The
Population as Patient: Alice Stewart and the Controversy over Low-Level
Radiation in the 1950s. To Treat or Not to Treat: Drug Research and the
Changing Nature of Essential Hypertension. Hormones at Risk: Cancer and the
Medical Uses of Industrially-Produced. Sex Steroids in Germany, 1930-1960.
Assessment and Medical Authority in Operative Fracture Care in the 1960 and
1970s. Assessing the Risk and Safety of the Pill: Maternal Mortality and
the Pill. Addressing Uncertainties: The Conceptualisation of Brain Death in
Switzerland 1960-2000. Risk on Trial. The Interaction of Innovation and
Risk in Cancer Clinical Trials. BioRisk: Interleukin-2 from Laboratory to
Market in the United States and Germany. The Redemption of Thalidomide:
Standardizing the Risk of Birth Defects
Preface. Risk and Medical Innovation: A Historical Perspective. To Assess
and to Improve: Practitioners? Approaches to Doubts Linked with Medical
Innovations 1720-1920. Anaesthesia and the Evaluation of Surgical Risk in
Mid-Nineteenth Century Britain. Redemption, Danger, and Risk: The History
of Anti-Bacterial Chemotherapy and the Transformation of Tuberculin. As
Safe as Milk or Sugar Water?: Perceptions of Risks and Benefits of the BCG
Vaccine in the 1920s and 1930s in France and Germany. From Danger to Risk:
The Perception and Regulation of X-Rays in Switzerland 1896-1970. The
Population as Patient: Alice Stewart and the Controversy over Low-Level
Radiation in the 1950s. To Treat or Not to Treat: Drug Research and the
Changing Nature of Essential Hypertension. Hormones at Risk: Cancer and the
Medical Uses of Industrially-Produced. Sex Steroids in Germany, 1930-1960.
Assessment and Medical Authority in Operative Fracture Care in the 1960 and
1970s. Assessing the Risk and Safety of the Pill: Maternal Mortality and
the Pill. Addressing Uncertainties: The Conceptualisation of Brain Death in
Switzerland 1960-2000. Risk on Trial. The Interaction of Innovation and
Risk in Cancer Clinical Trials. BioRisk: Interleukin-2 from Laboratory to
Market in the United States and Germany. The Redemption of Thalidomide:
Standardizing the Risk of Birth Defects
and to Improve: Practitioners? Approaches to Doubts Linked with Medical
Innovations 1720-1920. Anaesthesia and the Evaluation of Surgical Risk in
Mid-Nineteenth Century Britain. Redemption, Danger, and Risk: The History
of Anti-Bacterial Chemotherapy and the Transformation of Tuberculin. As
Safe as Milk or Sugar Water?: Perceptions of Risks and Benefits of the BCG
Vaccine in the 1920s and 1930s in France and Germany. From Danger to Risk:
The Perception and Regulation of X-Rays in Switzerland 1896-1970. The
Population as Patient: Alice Stewart and the Controversy over Low-Level
Radiation in the 1950s. To Treat or Not to Treat: Drug Research and the
Changing Nature of Essential Hypertension. Hormones at Risk: Cancer and the
Medical Uses of Industrially-Produced. Sex Steroids in Germany, 1930-1960.
Assessment and Medical Authority in Operative Fracture Care in the 1960 and
1970s. Assessing the Risk and Safety of the Pill: Maternal Mortality and
the Pill. Addressing Uncertainties: The Conceptualisation of Brain Death in
Switzerland 1960-2000. Risk on Trial. The Interaction of Innovation and
Risk in Cancer Clinical Trials. BioRisk: Interleukin-2 from Laboratory to
Market in the United States and Germany. The Redemption of Thalidomide:
Standardizing the Risk of Birth Defects